Japanese hospitals, BNCT, proton and heavy-ion therapy, precision diagnosis, university-hospital collaboration and cross-border care.
The Japanese term senshin iryo is often read as “the most advanced treatment available”. It is not. It is a defined slot in the public insurance system, with its own rules about who pays for what.
Pfizer Japan has launched Nurtec ODT (rimegepant, brand name ナルティークOD錠 75mg), the first oral CGRP-receptor antagonist available in Japan for both acute migraine treatment and prevention in the same tablet.
Carbon ion radiotherapy sits on Japan’s Advanced Medical Care A list as technique No. 2. Here is the official wording, the cost structure, and the seven hospitals the ministry lists.
A plain-language glossary for reading Japanese regenerative-medicine trials: jRCT, recruitment status, Phase I/II, eligibility and exclusion criteria, primary endpoints, adverse events, and conditional, time-limited approval.
Reading Japan’s iPS-based regenerative medicine through Amchepry, Heartseed HS-005 and the PMDA conditional, time-limited approval pathway — why it draws attention, and why the results still need careful interpretation.
What BNCT, proton beam and heavy-ion (carbon-ion) therapy each differ on: indication boundaries, current clinical-research status, and the documents worth preparing before making an enquiry.
Japan’s National Cancer Center is running a Phase I/II basket trial of BNCT for thoracic solid tumours. The trial design, who it is recruiting, how BNCT works, and the limitations patients should keep in mind.
Southern Tohoku General Hospital signed MOUs at a Shanghai medical-tourism exhibition, including with Shanghai Jiahui International Hospital. What this means in practice for patients in China looking into BNCT, proton therapy and cross-border care.
Based on published material from Nippon Medical School Hospital and its Yaesu health-screening centre: its role as a designated-function hospital, and its lung-cancer, gastrointestinal surgery, cardiovascular emergency, thyroid surgery and precision health-check systems.
Susumu Tonegawa, the first Japanese Nobel laureate in medicine, has died at 86. A tribute to his work on antibody diversity and memory — and to Japan’s six Nobel laureates in Physiology or Medicine.
